Article Sidebar

PDF
Date Published: 29/12/2021
Online Published: 06/01/2022
Abstract Views: 620
Views PDF: 290
DOI: https://doi.org/10.47972/vjcts.v35i.683
Issue
Vol. 35: SỐ ĐẶC BIỆT KỶ NIỆM 20 NĂM THÀNH LẬP BỆNH VIỆN TIM HÀ NỘI
Section
Research Article
How to Cite
Yen, H. T., Anh, V. D., Yen, L. T., & Dung, D. T. N. (2022). Double heterozygous familial hypercholesterolaemia: Case series, genetics and Cascade screening of families. The Vietnam Journal of Cardiovascular and Thoracic Surgery, 35, 75-83. https://doi.org/10.47972/vjcts.v35i.683

Double heterozygous familial hypercholesterolaemia: Case series, genetics and Cascade screening of families

Hoang Thi Yen , Vu Duc Anh, Le Thi Yen, Dang Thi Ngoc Dung

Main Article Content

Abstract

Background: Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metabolism characterized by high levels of LDL-cholesterol (LDL-C) in the blood. Studies identified more than 1,000 mutations of the LDLR gene in FH patients with incidence rates between 1: 500 and 1: 300. The mutation that occurs primarily in: LDLR, apoB, PCSK9, LDLRAP1 genes, 80% of which were detected the LDLR gene mutation. Nowaday, FH disease has not been paid much attention, leading to a delay in treatment. 


Objectives: identify mutations in other family members of the patient FH. 


Subjects and Methods: 14 family members of FH patients were gene analyzed, identified mutations on exons 4, 9 LDLR genes.


Results: 11/15 family members carrying heterozygous mutations on exon 4 and exon 9 of LDLR gene. Patient and 1 family member detected and treated late, leading to complications of myocardial infarction. Conclusion: Therefore, Cascade screening of patient's family members has an important role in early detection, genetic counseling and treatment, even in cases where pedigree members do not have xanthomas and no increase or slight increase in blood lipids. This is the basis for early counseling and treatment for members with mutations, reducing the risk of coronary artery diseases in the future.

Article Details

Keywords

exon 4, exon 9, LDLR gene mutation

References

1. Santos P.C, Morgan A.C, Jannes C.E et al (2014). Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 233 (1), 206-210.
2. Henderson R, O'Kane M, McGilligan V et al (2016). The genetics and screening of familial hypercholesterolaemia. J Biomed Sci, 23, 39.
3. DeMott K, Nherera L, Shaw E.J et al (2008). Clinical Guidelines and Evidence Review for Familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
4. Ranheim T, Kulseth M.A, Berge K.E et al (2006). Model system for phenotypic characterization of sequence variations in the LDL receptor gene. Clin Chem, 52(8), 1469-1479.
5. Chang J.H, Pan J.P, Tai D.Y et al (2003). Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. J Lipid Res, 44(10), 1850-1858.
6. Sozen M.M, Whittall R, Oner C et al (2005). The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis, 180(1), 63-71.
7. Khachadurian A.K (1964). The inheritance of essential familial hypercholesterolemia. Am J Med, 37, 402-7.